Dolby Laboratories, Inc. DLB Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $793.36M+37.3% | $577.75M-22.5% | $745.36M+20.2% | $620.13M-49.7% | ||
| $703K— | $0-100% | $139.15M-26.5% | $189.21M+387% | ||
| $519.22M+0.2% | $518.41M+14.1% | $454.2M+5.2% | $431.65M+1.8% | ||
| $30.42M-9.8% | $33.73M-5.3% | $35.62M+51.3% | $23.55M+115% | ||
| $1.39B+16.2% | $1.19B-19.7% | $1.49B+13.5% | $1.31B-25.5% | ||
| $470.61M-1.8% | $479.11M-0.5% | $481.58M-6.2% | $513.48M-3.9% | ||
| $529.9M-0.6% | $533.21M+30.6% | $408.41M+11.8% | $365.15M+7.2% | ||
| $397.06M-8.6% | $434.51M+160% | $167.43M+49.1% | $112.27M-8.6% | ||
| $80.21M-10.2% | $89.27M-8.7% | $97.81M-4.6% | $102.51M— | ||
| $3.23B+3.8% | $3.11B+4.4% | $2.98B+10.8% | $2.69B-13.4% | ||
| $17.84M+2.6% | $17.38M-16.9% | $20.93M+47.7% | $14.17M-20.3% | ||
| $31.38M-0.8% | $31.64M+0.4% | $31.51M+69.5% | $18.59M+0.6% | ||
| $437.79M+4.8% | $417.84M-1.0% | $422.23M+52.1% | $277.52M-12.1% | ||
| $595.81M-4.4% | $623.04M+2.5% | $607.58M+38.6% | $438.53M-12.5% | ||
| $2.63B+5.6% | $2.5B+4.4% | $2.39B+4.1% | $2.3B-11.9% | ||
| $2.62B+5.9% | $2.48B+5.2% | $2.36B+4.8% | $2.25B-13.5% | ||
| $3.23B+3.8% | $3.11B+4.4% | $2.98B+10.8% | $2.69B-13.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Can Dolby Laboratories, Inc. cover its short-term obligations?
- Its current ratio is 2.98 — current assets exceed current liabilities.
- Where does Dolby Laboratories, Inc.'s balance sheet data come from?
- Every line is extracted from Dolby Laboratories, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.